[1]王晓冰,杨清绪,裴小娟,等.乳腺浸润性癌血管生成相关因子的表达及其临床意义[J].南方医科大学学报,2006,(06):860-863.
 WANG Xiao-bing,YANG Qing-xu,PEI Xiao-juan Department of Pathology,et al.Expression of angiogenesis-related factors in invasive breast cancer and its clinical significance[J].Journal of Southern Medical University,2006,(06):860-863.
点击复制

乳腺浸润性癌血管生成相关因子的表达及其临床意义()
分享到:

《南方医科大学学报》[ISSN:1673-4254/CN:44-1627/R]

卷:
期数:
2006年06期
页码:
860-863
栏目:
论著·临床研究
出版日期:
2000-01-01

文章信息/Info

Title:
Expression of angiogenesis-related factors in invasive breast cancer and its clinical significance
作者:
王晓冰; 杨清绪; 裴小娟;
惠州市中心人民医院病理科; 惠州市中心人民医院病理科 广东惠州516001; 广东惠州516001;
Author(s):
WANG Xiao-bing YANG Qing-xu PEI Xiao-juan Department of Pathology Huizhou Central Hospital Huizhou 516001 China
关键词:
乳腺癌 微血管计数 VEGF TGFβ1
Keywords:
breast carcinoma microvessel count vascular endothelial growth factor transforming growth factor-β1
分类号:
R737.9
摘要:
目的探讨乳腺浸润性癌血管生成相关因子(VEGF,TGFβ1)的表达与微血管计数(MVC)之间的关系及其临床意义。方法经手术治疗的乳腺浸润性癌62例及12例正常乳腺组织,分别进行HE染色和CD34、VEGF及TGFβ1的免疫组化染色。根据CD34阳性结果计数测定MVC。记录乳腺浸润性癌患者的临床病理特征如年龄、肿瘤大小、病理分型及有无腋淋巴结转移等资料,并将MVC、VEGF和TGFβ1表达结果分别与上述指标进行统计分析。结果乳腺浸润性癌组织MVC值(55.62±11.07)、VEGF和TGFβ1阳性表达率(分别为51.61%和56.45%)均显著高于正常乳腺组织(分别为12.65±5.73,16.67%,16.67%)(P<0.05);MVC值在有腋淋巴结转组(65.53±20.36)高于无腋淋巴结转移组(46.15±16.52),差异有显著性(P<0.01);VEGF和TGFβ1表达的阳性率在有腋淋巴结转移组(分别为68.75%和78.13%)高于无腋淋巴结转移组(均为33.33%),差异有显著性(P<0.05);当VEGF或TGFβ1表达阳性时,MVC值增高(分别为62.82±16.31和59.35±12.76),与VEGF或TGFβ1表达阴性组(分别为51.16±12.53和50.80±15.62)比较差异有显著性(P<0.05);VEGF和TGFβ1之间也存在较明显的相关性(P<0.05)。结论VEGF和TGFβ1相互作用介导了肿瘤血管生成,MVC、VEGF和TGFβ1与淋巴结转移密切相关,可作为判断乳腺浸润性癌预后的参考指标。?
Abstract:
Objective To investigate the relation between expression of angiogenesis-related factors, namely vascular endothelial growth factor (VEGF) and transforming growth factor-β1 (TGFβ1), and microvessel count (MVC) in invasive breast cancer and analyze its clinical implications. Methods VEGF, TGFβ1 and CD34 expressions in 62 surgical specimens of invasive breast cancer and 12 normal breast specimens were examined by immunohistochemistry and HE staining. MVC was calculated according to the quantification of positive CD34 expression. Clinicopathological characteristics of the patients including age, tumor size, histological type and auxiliary lymph node metastasis were recorded and compared with the results of MVC VEGF and TGFβ1 expression and detection. Results MVC and of VEGF and expressions TGFβ1 in invasive breast cancer group (55.62±11.07, 51.61%, 56.45%, respectively) were greater than those in the normal control group (12.65±5.73, 16.67%, 16.67%, respectively, P<0.05). MVC and the positivity rates of VEGF and TGFβ1 expressions were 65.53±20.36, 68.75% and 78.13%, respectively, in invasive breast cancer patients with axillary lymph node metastasis, significantly higher than those without metastasis (P<0.05). MVC was correlated with VEGF and TGFβ1 expressions in that MVC was significantly higher in patients positive for VEGF and TGFβ1 (62.82±16.31 and 59.35±12.76) than in those negative for their expressions (51.16±12.53 and 50.80±15.62, P<0.05). Significant correlation was also found between VEGF and TGFβ1 expressions (P<0.05). Conclusion The interaction between VEGF and TGFβ1 mediates angiogenesis, and MVC and VEGF and TGFβ1 expressions are correlated to lymph node metastasis, which may provide reference for prognostic evaluation of invasive breast cancer.?

相似文献/References:

[1]黄伟斌,姚广裕,刘民锋,等.心肌钙蛋白I 对蒽环类化疗的乳腺癌患者心脏毒性的预测价值[J].南方医科大学学报,2011,(06):1047.
[2]郭启帅,黄曦,李少林.沉默PeroxiredoxinⅠ基因对乳腺癌裸鼠移植瘤放射敏感性的影响[J].南方医科大学学报,2011,(07):1119.
[3]冯云,周会行,李军红,等.肝癌缺失基因1和磷酸化粘着斑激酶蛋白在乳腺癌组织中的表达及意义[J].南方医科大学学报,2011,(08):1448.
[4]夏青,史艳侠,刘东耕,等.一项单中心的25例男性乳腺癌临床病理特点总结[J].南方医科大学学报,2011,(09):1469.
[5]李嗣杰,贾泓瑶,吴迪,等.肿瘤翻译调控蛋白在人乳腺癌组织中的表达及临床意义[J].南方医科大学学报,2011,(09):1560.
[6]马吉光,王宁菊,于文洁.“三阴”型与非“三阴”型乳腺癌患者的生物学行为差异性分析[J].南方医科大学学报,2011,(10):1729.
[7]王玲,单保恩,桑梅香,等.靶向沉默p65 基因对人乳腺癌细胞MDA-MB-231增殖及凋亡的影响[J].南方医科大学学报,2011,(10):1742.
[8]陈可和,梁博,邹镇洪,等.Rheb和Rheb’D60K突变基因重组慢病毒载体的构建、鉴定及其对肝癌细胞凋亡的影响[J].南方医科大学学报,2012,(03):341.
[9]胡孝渠,秦利,苏逢锡,等.载体介导HER-2RNA干扰治疗乳腺癌研究[J].南方医科大学学报,2006,(05):570.
 HU Xiao-qu,QIN Li,SU Feng-xi,et al.Vector-mediated HER-2 RNA interference against HER-2-positive breast cancer[J].Journal of Southern Medical University,2006,(06):570.
[10]崔斐,罗荣城,陈锦章,等.紫杉醇联合Herceptin或表阿霉素治疗Her-2/neu阳性乳腺癌患者的临床疗效[J].南方医科大学学报,2005,(12):1533.
 CUI Fei,LUO Rong-cheng,CHEN Jin-zhang,et al.Therapeutic effect of TAX combined with Herceptin or epirubicin against breast cancer positive for Her-2/neu[J].Journal of Southern Medical University,2005,(06):1533.

更新日期/Last Update: 1900-01-01